Internal Medicine
Partner With Us
Advertisement
Conexiant chevron_right Internal Medicine chevron_right Upfront Cost Guidance Limited in US Guidelines
From the Journals Clinical Guidelines

Upfront Cost Guidance Limited in US Guidelines

Although most large US-based medical societies in a cross-sectional study explicitly suggested considering economic or resource use–related evidence during guideline development, only 3.8% of individual recommendations included that information in the recommendation statement itself.

Conexiant

Clinical Scorecard: Upfront Cost Guidance Limited in US Guidelines

At a Glance

CategoryDetail
ConditionEconomic and resource use guidance in clinical practice guidelines
Key MechanismsIncorporation of economic data and resource use against health benefits in clinical recommendations
Target PopulationPatients and healthcare providers in the US
Care SettingClinical practice guideline development

Key Highlights

  • Only 3.8% of recommendations included upfront economic guidance.
  • 76% of guideline documents contained at least one narrative discussion on economic evidence.
  • Primary care societies were more likely to include upfront economic statements than specialty societies.
  • Economic considerations are increasingly addressed in guideline development over time.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients facing rising out-of-pocket costs

          Patients expect clinicians to practice value-based care.

          Clinical Best Practices

          • Consider economic and resource use evidence during guideline development.
          • Encourage primary care societies to lead in incorporating economic guidance.

          Related Resources & Content

          Daily News

          Stay up to date with the latest clinical headlines and other information tailored to your specialty.